These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36414666)

  • 1. DeepPROTACs is a deep learning-based targeted degradation predictor for PROTACs.
    Li F; Hu Q; Zhang X; Sun R; Liu Z; Wu S; Tian S; Ma X; Dai Z; Yang X; Gao S; Bai F
    Nat Commun; 2022 Nov; 13(1):7133. PubMed ID: 36414666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DiffPROTACs is a deep learning-based generator for proteolysis targeting chimeras.
    Li F; Hu Q; Zhou Y; Yang H; Bai F
    Brief Bioinform; 2024 Jul; 25(5):. PubMed ID: 39101502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DeepSA: a deep-learning driven predictor of compound synthesis accessibility.
    Wang S; Wang L; Li F; Bai F
    J Cheminform; 2023 Nov; 15(1):103. PubMed ID: 37919805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PROTAC-DB: an online database of PROTACs.
    Weng G; Shen C; Cao D; Gao J; Dong X; He Q; Yang B; Li D; Wu J; Hou T
    Nucleic Acids Res; 2021 Jan; 49(D1):D1381-D1387. PubMed ID: 33010159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PROTACable Is an Integrative Computational Pipeline of 3-D Modeling and Deep Learning To Automate the De Novo Design of PROTACs.
    Mslati H; Gentile F; Pandey M; Ban F; Cherkasov A
    J Chem Inf Model; 2024 Apr; 64(8):3034-3046. PubMed ID: 38504115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of E3 Ligase Ligands for Target Protein Degradation.
    Lee J; Lee Y; Jung YM; Park JH; Yoo HS; Park J
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Induced degradation of proteins by PROTACs and other strategies: towards promising drugs].
    Reboud-Ravaux M
    Biol Aujourdhui; 2021; 215(1-2):25-43. PubMed ID: 34397373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolysis-targeting chimeras (PROTACs) in cancer therapy.
    Li X; Pu W; Zheng Q; Ai M; Chen S; Peng Y
    Mol Cancer; 2022 Apr; 21(1):99. PubMed ID: 35410300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BindWeb: A web server for ligand binding residue and pocket prediction from protein structures.
    Xia Y; Xia C; Pan X; Shen HB
    Protein Sci; 2022 Dec; 31(12):e4462. PubMed ID: 36190332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule PROTACs: novel agents for cancer therapy.
    Wan Y; Yan C; Gao H; Liu T
    Future Med Chem; 2020 May; 12(10):915-938. PubMed ID: 32270707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound-protein interaction prediction with end-to-end learning of neural networks for graphs and sequences.
    Tsubaki M; Tomii K; Sese J
    Bioinformatics; 2019 Jan; 35(2):309-318. PubMed ID: 29982330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved protein relative solvent accessibility prediction using deep multi-view feature learning framework.
    Fan XQ; Hu J; Jia NX; Yu DJ; Zhang GJ
    Anal Biochem; 2021 Oct; 631():114358. PubMed ID: 34478704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An In Vitro Pull-down Assay of the E3 Ligase:PROTAC:Substrate Ternary Complex to Identify Effective PROTACs.
    Bondeson DP; Smith BE; Buhimschi AD
    Methods Mol Biol; 2021; 2365():135-150. PubMed ID: 34432242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bionoi: A Voronoi Diagram-Based Representation of Ligand-Binding Sites in Proteins for Machine Learning Applications.
    Feinstein J; Shi W; Ramanujam J; Brylinski M
    Methods Mol Biol; 2021; 2266():299-312. PubMed ID: 33759134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convolutional neural networks with image representation of amino acid sequences for protein function prediction.
    Sara ST; Hasan MM; Ahmad A; Shatabda S
    Comput Biol Chem; 2021 Jun; 92():107494. PubMed ID: 33930742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs.
    Bai N; Riching KM; Makaju A; Wu H; Acker TM; Ou SC; Zhang Y; Shen X; Bulloch DN; Rui H; Gibson BW; Daniels DL; Urh M; Rock BM; Humphreys SC
    J Biol Chem; 2022 Apr; 298(4):101653. PubMed ID: 35101445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerating PROTAC drug discovery: Establishing a relationship between ubiquitination and target protein degradation.
    Gross PH; Sheets KJ; Warren NA; Ghosh S; Varghese RE; Wass KWass KE; Kadimisetty K
    Biochem Biophys Res Commun; 2022 Nov; 628():68-75. PubMed ID: 36084553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase.
    Smith BE; Wang SL; Jaime-Figueroa S; Harbin A; Wang J; Hamman BD; Crews CM
    Nat Commun; 2019 Jan; 10(1):131. PubMed ID: 30631068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic potential of PROTACs.
    Benowitz AB; Jones KL; Harling JD
    Expert Opin Ther Pat; 2021 Jan; 31(1):1-24. PubMed ID: 33081540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein secondary structure prediction improved by recurrent neural networks integrated with two-dimensional convolutional neural networks.
    Guo Y; Wang B; Li W; Yang B
    J Bioinform Comput Biol; 2018 Oct; 16(5):1850021. PubMed ID: 30419785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.